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Solid state NMRTwo key commonly used cannabinergic agonists, CP55940 and WIN55212-2, are investigated for their effects
on the lipid membrane bilayer using 2H solid state NMR, and the results are compared with our earlier work
with delta-9-tetrahydrocannabinol (Δ9-THC). To study the effects of these ligands we used hydrated bilayers
of dipalmitoylphosphatidylcholine (DPPC) deuterated at the 2′ and 16′ positions of both acyl chains with
deuterium atoms serving as probes for the dynamic and phase changes at the membrane interface and at the
bilayer center respectively. All three cannabinergic ligands lower the phospholipid membrane phase
transition temperature, increase the lipid sn-2 chain order parameter at the membrane interface and decrease
the order at the center of the bilayer.
Our studies show that the cannabinoid ligands induce lateral phase separation in the lipid membrane at
physiological temperatures. During the lipid membrane phase transition, the cooperative dynamic process
whereby the C-2H segments at the interface and center of the bilayer spontaneously reach the fast exchange
regime (2H NMR timescale) is distinctively modulated by the two cannabinoids. Speciﬁcally, CP55940 is
slightly more efﬁcient at inducing liquid crystalline-type 2H NMR spectral features at the membrane interface
compared to WIN55212-2. In contrast, WIN55212-2 has a far superior ability to induce liquid crystalline-type
spectral features at the center of the bilayer, and it increases the order parameter of the sn-1 chain in addition
to the sn-2 chain of the lipids. These observations suggest the cannabinoid ligands may inﬂuence lipid
membrane domain formations and there may be contributions to their cannabinergic activities through lipid
membrane microdomain related mechanisms. Our work demonstrates that experimental design strategies
utilizing speciﬁcally deuterium labeled lipids yield more detailed insights concerning the properties of lipid
bilayers.116 Mugar Hall, Northeastern
200; fax: +1 617 373 7493.
nnis).
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It is generally accepted that the phospholipidmicroenvironment can
inﬂuence membrane protein function, and indeed recent pharmaco-
logical studies indicate that lipid membrane integrity has a profound
effect on the functions of cannabinoid receptors [1–3]. Thus, it is
beneﬁcial to carefully evaluate the perturbation effects of widely used
cannabinergic ligands on membrane systems in order to obtain a more
complete understanding of their pharmacological proﬁles. Our earlier
studies on the ability of classical cannabinoids (Δ8-THC/Δ9-THC) to
perturb membrane bilayers have suggested that cannabinoid biological
activities may be exerted in part by modulating the thermodynamic
properties of the cellular membrane bilayer [4–7].
A series of NMR studies showed that the site and geometry of
hydroxyl groups on classical cannabinoids can affect the orientation of
the ligand in a membrane environment [6–13]. In Δ9-THC thephenolic hydroxy group associates with the hydrophilic head groups
of the phospholipids within the bilayer. This causes the long axis of
the molecule to orient perpendicular to the phospholipid chains,
conversely, the O-methyl, biologically inactive analog orients with its
long axis parallel to the phospholipid acyl chains. Cannabinergic
ligands carrying more than one polar hydroxyl group orient in a
manner that allows all hydroxyl groups to orient towards the
corresponding polar membrane interface [6–14].
Amphipathic conformational characteristics were deﬁned in solu-
tion studies of the conformationaly ﬂexible non-classic CP55940
compound (Fig. 1). In a chloroform solution, all three hydroxyl groups
were oriented on the same face of the bicyclic rings, most likely
stabilized byhydrogenbonding between them [15]. The dimethylheptyl
side chain adopted one of four preferred conformations, in all of which
the chain is almost perpendicular to the phenol ring. A study of a two
conformationaly restrained, diastereomeric nonclassical cannabinoids,
CP55,244 and CP97,587, showed that hydrogen bonding between
hydroxyl groups is indeed responsible for an increase in the conforma-
tional population in which all hydroxyl groups are located on the same
face of the ring system [16].
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Fig. 1. Structure of CP55940, WIN55212-2, Δ8-THC and dipalmitoyl phosphotidylcho-
line (DPPC) with the labeled 2′ and 16′ positions highlighted.
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measured NOE's proving that, in a bilayer, Δ8-THC was indeed in
the “amphipathic conformation”. No such NOEs were observed for
Me-Δ8-THC congruent with the notion that the long axis of this more
lipophilic analog is aligned with lipid molecules so that the side chain
group extends away from the ring system [18,19]. Anisotropic
measurements further proved that Δ8-THC and Me-Δ8-THC are
oriented perpendicular and parallel, respectively, in the bicelle
environment consistent with their observed conformations.
In this study, we measure the interactions, within phospholipid
model membranes, of CP55940 and WIN55212-2; two ligands that
have been widely employed as pharmacological benchmark com-
pounds [20,21] and whose conformational properties have been
studied [15,22]. The biological effects of those ligands have been
primarily attributed to their interactions with membrane associated
cannabinoid receptors, members of the GPCR rhodopsin family [23–
25]. Both compounds are potent cannabinoid receptor agonists, but
have distinctly different structural features [26–28].
Membranes prepared from hydrated, fully deuterated phospholi-
pids have been widely employed to study ligand effects on
membranes, including, determination of order parameter proﬁles
using solid state 2H NMR methods [29–31]. A recent study describes
the effects of a series of cannabinoids on the order parameter along
the length of the lipids in oriented bicelles. However, 2H NMR spectra
and quadrupolar splittings obtained from fully deuterated bilayers are
severely overlapped and prevent a detailed spectral analysis. Thus,
differences between sn-1 and sn-2 chains of DPPC are not discernible
[29]. Additionally the thermotropic spectral changes accompanying
phase transitions within the membrane cannot be studied. For these
reasons, the DPPC phospholipid molecule used in this study was
synthesized with 2H speciﬁcally labeled only at the 2′ or 16′ positions
on each of the DPPC acyl chains (Fig. 1). Thus we speciﬁcally monitor
the ligand effect at the bilayer center and near its interface and are
able to detect subtle, ligand induced, changes in the local dynamics of
the speciﬁc lipid methylene segments through careful observation of
spectral changes. Our results contribute to the understanding of the
role of phospholipid membranes in the molecular mechanism of
cannabinergic function.2. Methods
2.1. Materials
The speciﬁcally deuterium labeled phospholipid molecules 1,2-
[2′,2′-2H2]-DPPC and 1,2-[16′,16′,16′-2H3]-DPPC were synthesized in
our laboratory according to literature procedures [32], unlabeled
DPPC was purchased from Avanti Polar Lipids, Birmingham, AL.
WIN55212-2 and CP55940 were obtained from the National Institute
of Drug Abuse. Deuterium depleted water and chloroform were
purchased from Aldrich.
2.2. Sample preparation
Appropriate amounts of each cannabinergic ligand and speciﬁcally
deuterated DPPC phospholipid were dissolved in 2 ml of chloroform
to produce a 0.1 drug/lipid molar ratio solution. The solvent was then
evaporated by passing a stream of nitrogen over the solution at room
temperature and the residue was placed under vacuum (0.1 mm Hg)
for 12 h. The MLV phospholipid membrane with a 50:50 (w/w) lipid/
water hydration level was produced by adding an appropriate amount
of deuterium depleted water to the dried sample which was subjected
to a freeze-thawing and vortexing procedure as described previously
[5]. The membrane preparation was then introduced into a 5-mm
glass tube and ﬂame sealed under vacuum.
2.3. 2H-solid state spectroscopy
NMR experiments were performed on a Chemagnetics solid state
spectrometerwith a staticwideline probe operating at amagneticﬁeld
of 6.9 T (46.6 MHz for 2H), using the quadrupole echo pulse sequence,
[(π/2)x−τ−(π/2)y], with τ=35 μs and a recycle delay of 200 ms.
Sample temperatures were regulated by the Chemagnetics tempera-
ture controller. Before recording the spectra, samples were held at
50 °C for 15 min to ensure complete equilibrium, and subsequently
held at the designated temperature for another 10 min. 2H NMR
experiments from each ligand containing sample were performed
parallel with the control sample of hydrated DPPC bilayers.
3. Results
3.1. Temperature dependent 2H Spectra of 1,2-[16′,16′,16′-2H3]-DPPC
phospholipid membranes
Fig. 2 depicts the temperature dependent static solid state, 2H NMR
spectra obtained from DPPC phospholipid membranes into which
CP55940 or WIN55212-2 where incorporated at 10 mol%. At tem-
peratures above 41.5 °C, the control spectra are in the liquid
crystalline phase (Fig. 2A). The six magnetically equivalent deuterons
on each DPPC molecule give rise to a single well-deﬁned “Pake
Pattern” with a quadrupolar splitting of ΔυQ=3.2 kHz. At tempera-
tures below 41.5 °C, the control spectra undergo drastic broadening,
an indication that the lipid membrane undergoes a sharp phase
transition. This observation is consistent with the results from DSC
experiments [5] and is attributable to a signiﬁcant reduction of the
motion of C-2H2 segments on the lipid acyl chains in the gel phase.
Fig. 2B and C depict the temperature dependent 2H NMR spectra of
the 16′-labeled phospholipid bilayer acyl chains from 30 °C to 45 °C,
obtained with the presence of 10 mol% of CP55940 and WIN55212-2.
The results indicate that both ligands reduce the phase transition
temperature as both CP55940 and WIN55212-2 exhibit liquid
crystalline lineshapes at 39 °C. At 37 °C there is a clear spectral
superposition of characteristic liquid crystal and gel lineshapes clearly
indicating the co-existence of these two components. As the
temperature is lowered, the gel spectral features become more
prominent. However, there are also distinct differences between the
Fig. 2. Temperature dependent solid-state 2HNMR spectra obtained from fully hydratedmultilamelar vesicles prepared from 1, 2[16′,16′,16′-2H3]DPPC. (A) Control, (B)with 10 mol%
CP55940, and (C) with 10 mol% WIN55212-2.
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features persist until 39 °C; while at 37 °C, there is a broadening of the
peaks and merging with the gel like spectral features which
progressively dominate the lower temperature spectra. Conversely,
in the WIN55212-2 spectra, the sharp 90° edges of the liquid crystal
spectrum remain distinct down to 30 °C, while their spectral
contribution gradually diminishes.
We have also compared the 2H splittings associated with the liquid
crystal spectral component. At 45 °C the quadrupolar splittings are
reduced from 3.2 kHz for the control, to 2.9 kHz and 2.7 kHz
respectively for the CP55940 and WIN55212-2 preparations. This
suggests that at the center of the bilayer, each of the ligands reduces
the acyl chain order parameter and “enhanced ﬂuidity” with
WIN55212-2 having the more prominent effect.
3.2. Temperature dependent 2H spectra of 1,2-[2′,2′-2H2]-DPPC
phospholipid membranes
The 2H-labels at the 2′ positions of the sn-1 and sn-2 chains help to
monitor the phase and the order parameter changes at the lipidFig. 3. Temperature dependent solid-state 2H NMR spectra obtained from fully hydrated m
CP55940, and (C) with 10 mol% WIN55212-2.membrane interface induced by each of the ligands as a function of
temperature. Fig. 3 shows the temperature dependent spectra of the
ligand free phospholipidmembrane control and the 10 mol% CP55940
or WIN55212-2 membrane preparations. At temperatures above
41.5 °C, the control spectra exhibit complete liquid crystalline features
(Fig. 3A) and give rise to three quadrupolar splittings of 12.0, 17.8 and
26.7 kHz, as opposed to a single quadrupolar splitting from 1,2-
[16′,16′,16′-2H3]-DPPC (Fig. 2A). According to an earlier assignment at
45 °C, the 17.8 kHz and 12.0 kHz couplings arise from the stereo-
chemically inequivalent 2′R-2H and 2′S-2H on the sn-2 chain, and the
26.7 kHz coupling arises from the 2′-2H2 on the sn-1 chain [5]. As the
temperature is lowered, the control spectra undergo broadening,
consistent with phase transformation (Fig. 2A). This progressive
change of the deuterium NMR lineshape is attributable to a signiﬁcant
reduction of the rate of trans–gauche interconversion of deuterated
methylene segments of the lipid acyl chains near the interface.
At 45 °C, the spectra from both CP55940 (Fig. 3B) and WIN55212
(Fig. 3C) membrane preparations show completed and well-resolved
quadrupolar splittings, characteristic of a liquid crystal phase [31]. At
41.5 °C, shoulders arising from the gel-like phase become visible forultilamelar vesicles prepared from 1, 2[2′,2′-2H2]DPPC. (A) Control, (B) with 10 mol%
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separation and restricted the rate of the 2′ segment trans–gauche
interconversion near the phospholipid head group and interface. This
effect gradually increases as the temperature is lowered but is more
prominent in the WIN55212-2 spectra.
At 39 °C, the spectrum from the control membrane shows a ﬂat
top, conical shape, while the CP55940 and WIN55212-2 spectra show
a sharp Pake pattern protruding from broadened rounded shoulders.
This is attributable to a superimposition of spectral features
characteristic of liquid crystalline and gel phases suggesting their
individual contributions within the sample. The contribution from the
gel phase components progressively increases for both compounds as
the temperature is lowered however at lower temperatures there is a
larger contribution from the liquid crystal phase in the CP55940
spectra (Fig. 3B&C). At 30 °C, for example, the spectra from the ligand
free control membrane and theWIN55212-2 containing sample show
typical gel phase spectral features with a conical shape and a rounded
top. However, the CP55940 spectrum has a discernable ﬂat top
appearance suggesting higher mobility for a detectable population of
DPPCmolecules at this temperature. This suggests that CP55940more
effectively maintains liquid crystalline conditions at the membrane–
water interface and may induce phase separation at these
temperatures.
The quadrupolar coupling ΔυQ values due to the [2,2′-2H2]
segment of DPPC as measured at 45 °C are also modulated by
incorporation of cannabinoid ligands (Table 1). In the liquid
crystalline phase, the lipid segment order parameter SCD may be
directly derived from the experimental 2H NMR spectra. SCD is related
to the quadrupolar splitting ΔνQ between the 90° singularities by
ΔνQ=−3/4(e2qQ/h)SCD, where e2qQ/h is the static quadrupolar
coupling constant. Both CP55940 and WIN55212-2 increased the
ΔυQ values for both deuterons of the sn-2 chain. These increases could
result from an increase of the order parameter of the 2′-methylene
segments of the sn-2 chain. The increased order parameter may be
due to inter-molecular hydrogen bonding between the lipid sn-2
carbonyl group and the hydroxyl groups on the CP55940 or the
morpholino group of WIN55212-2. The ΔυQ value of the 2′-2H2 on the
sn-1 chain of DPPC is also sensitive to the presence of the cannabinoid
ligands. WIN55212-2 increases the ΔυQ value from 26.7 kHz to
27.3 kHz, while CP55940 has only a marginal effect on the sn-1
dynamics at this region, with a slightly altered quadrupolar splitting
of 26.6 kHz. Thus the order parameter changes in the sn-1 chain are
more sensitive to WIN55212-2.
4. Discussion
Lipid membrane preparations composed of speciﬁcally 2H labeled
DPPC, hydrated multi-lamellar bilayers provide a relevant model for
studying drug–membrane interactions. While full deuteration of
phospholipids may reduce the phase transition temperature of the
bilayer [33], we have found from DSC and 2H temperature dependent
spectra (Figs. 2 & 3) that selective deuteration of a single phospholipid
site maintains very similar thermotropic properties as the undeuter-
ated lipid bilayers. Speciﬁcally deuterated phospholipids are, there-Table 1
Solid state 2H NMR quadrupolar splittings (ΔνQ) from 2H-labeled DPPC bilayers in the
absence and presence of 10% CP55940 and 10%WIN55212-2, measured at 45 °C.
2H-label positions
on DPPC
Quadrupolar splitting ΔυQ (kHz)
Control CP55940 WIN55212-2 THCa
1,2-[16′,16′,16′-2H3] 3.2 2.9 2.7 2.3
1-[2′,2′-2H2] 26.7 26.6 27.3 27.1
2-[2′S-2H] 12.0 13.1 12.9 14.1
2-[2′R-2H] 17.8 18.1 18.7 18.9
a Data extracted from reference [5].fore, less invasive markers for studying phospholipid membrane
phase behavior, structure, and dynamic properties using 2H NMR. As a
result, more detailed and subtle ligand effects on the phospholipid
membrane system may be detected at temperature ranges close to
physiological conditions. Signiﬁcantly, the control (ligand free lipid
membrane) samples at the same condition demonstrate a close
correspondence between the collective phase behavior and the
synchronized evolution of the 2H NMR spectral lineshape from the
two different sites along the lipid acyl-chains.
Our results show that both ligands lower themain phase transition
temperature of the DPPC membrane bilayer, as indicated by the
presence of liquid crystal features within the 2H spectra at
temperatures below 41.5 °C. This effect, frequently found for many
anesthetics [34–36], has also been observed with other cannabinoids
[4,37]. Additionally, the phase transition of the phospholipid bilayer
accompanying reduction in temperature is signiﬁcantly ligand
dependent. Incorporation of either of the ligands, leads to 2H-DPPC
spectral inhomogeneity, with two slowly exchanging components
within the NMR timescale as indicated by the superimposed sharp
and broadened spectral lineshapes. The superimposed spectra
indicate a possible ligand-induced lipid membrane lateral phase
separation, which is often associated with domain formation as has
been demonstrated for membranes with multiple lipid components
[38]. We speculate that our observed superimposed spectral features
may also be the result of cannabinoid-induced lipid membrane lateral
phase separation and domain formation. However, the data may also
be accounted for by a uniform distribution of ligand throughout the
membrane, undergoing a slow or intermediate exchange between
two distinct conformations on the NMR time scale.
4.1. Differential ligand effects at the center and interface of the
lipid bilayer
A careful examination of the 2H-spectra in Figs. 2 and 3 reveals that
the ligand-associated effects on the bilayer interface are distinctly
different from those at the center of the bilayer. The spectra from the
labeled lipid segments at the surface and the center of the bilayer
demonstrate “out-of-sync” or un-coordinated 2H NMR spectroscopic
features at temperatures that the lipid undergoes the “thermotropic
phase transition”. In contrast, the spectra obtained from the control,
non ligand-containing lipid membrane samples show congruent
spectra from each label at any given temperature. Thus, the presence
of WIN55121-2 and CP55940 alters the timescale proﬁle of the lipid
chain trans–gauche interconversion dynamics or the local segment
order parameter at different temperatures. Perturbations of the
bilayer by the ligands may result in speciﬁc chain segments to fall in
the fast exchange regime on the 2H NMR timescale (10−5 s), that
yields “liquid crystalline-type” spectral features in comparison to our
control experiments. This suggests a ligand-induced timescale
discontinuity between the interface and the central component of
the bilayer acyl chains during the phase transition.
A close inspection of the spectra allows us to estimate the fraction
of liquid crystalline-type spectral component within each spectrum.
Based on the contribution of gel-type and liquid crystalline-type
spectral components, our results indicate that at 39 °C, for the 1, 2-
[2′,2′-2H2]-DPPC membranes (Figs. 3 & 4), approximately 90% of the
total lineshape is dominated by liquid crystal features for the CP55940
sample as opposed to approximately 50% for theWIN55212-2 sample.
Conversely, the data from the 1,2-[16′,16′,16′-2H3]-DPPC (Figs. 2 & 4),
indicate that at 39 °C, the center of the phospholipid bilayer is entirely
in fast exchange regime and gives almost completed liquid crystal-
line-type spectra for both cannabinoid ligands. This suggests that at
39 °C, the ligands may induce a lateral phase separation in DPPC lipid
membrane such that a portion of the phospholipids remains in the gel
phase with the majority of the lipids in the liquid crystalline phase.
Interestingly, CP55940 is more effective compared to WIN55212-2 at
Fig. 4. Schematic representation of cannabinoid ligand location, orientation and effects on the lipidmembrane phase at 39 °C. The 2H spectrameasured from the bilayer interface (2′-2H labels)
and from the center of the bilayer (16′-2H labels) are also shown. A) Pure DPPC lipid membrane is in the gel phase and both interface and center deuterium labels give broadened lineshapes.
B)DPPCmembraneswithCP55940 are in a liquid crystalline phase. The likely position andorientationof CP55940 is shown. C)WIN55212-2 also lowers the lipid phase transition temperature. It
anchors at the membrane interface most likely through its morpholine ring and extends its ﬂexible hydrophobic aromatic rings deep into the bilayer center.
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surface of the membrane.
At lower temperatures, the differential effect on the spectral
features between the two sites within the ligand-containing mem-
brane is more discernible and is clearly ligand dependant. For the
CP55940 sample at 35 °C, the spectra from the 16′ deuterium label
indicate that the membrane center is predominantly in a gel phase
type of slow motion, while the well-resolved quadrupolar splitting
fraction in the spectra from the labels at 2′ position indicates that a
signiﬁcant part of the phospholipid membrane at the interface is in a
fast exchange regime. Conversely, for the WIN55212-2 containing
membrane at 35 °C, the spectrum of the interface 2H-labels at the 2′
position exhibits a predominantly gel-type lineshape. The 16′ 2H
labels at the bilayer center exhibit a superimposed spectrum with a
substantial proportion of the liquid crystalline-type component with
sharp 90° edges, which indicates that WIN55212-2 keeps a consid-
erable fraction of the C-2H segments at bilayer center in the fast
exchange regime.
This differential effect is particularly strong in the WIN55212-2
spectra at 30 °C, where the bilayer interface yields an entirely gel-type
lineshape, while the spectrum from the bilayer center gives a
considerable fraction of liquid crystalline-type spectral component.
This indicates a signiﬁcant portion of the lipid segments at the center
is in a fast exchange regime. We attribute the above observations to
cannabinoid ligand-induced microscopic defects at the ligand-speciﬁc
site(s) within lipid bilayer, which may cause a fraction of the lipid
chain segments to fall in a fast exchange regime in the 2H NMRFig. 5. The 2H NMR spectra, and illustration of the interpreted effects of WIN55212-2 on the
gives broadened gel-type spectral lineshapes from the deuterium labels at the interface an
spectral lineshape from the lipid bilayer interface, and a superimposed gel/liquid crystal
microscopic defects at the lipid bilayer center may cause a fraction of the lipid chain segmen
liquid-crystalline-like spectral features. Depending on the distribution property of the ligand
within the lipid bilayer.timescale and result in liquid-crystalline-like spectral features. Fig. 5
illustrates our proposed interpretation for the case of WIN55212-2.
Depending on the distribution properties of the ligand in the lipid
membrane, these ligand-induced membrane defects could be either
clustered (Fig. 5B) or dispersed (Fig. 5C), within the lipid bilayer.
4.2. WIN55212-2 and CP55940 alter the lipid bilayer order
parameter differently
The quadrupolar splitting (ΔυQ) data obtained from the phospho-
lipid membrane in the liquid crystalline phase reﬂects the local order
parameter induced by the cannabinergic ligands. Table 1 summarizes
the ΔυQ values from the 2H spectra of two sets of speciﬁc 2H-labeled
DPPC preparations in the absence and presence of 10% CP55940 and
WIN55212-2 at 45 °C. ΔυQ data obtained from the earlier studies of
Δ8-THC/DPPC system are also included in the table for comparison.
The presence of either CP55940 or WIN55212-2 increases the ΔυQ
values of the 1,2-[2′,2′-2H2] segments of DPPC lipid membrane, as
shown in Table 1. This is interpreted as an increase of order parameter of
the 2′-methylene segments imposed by the presence of the ligand [5].
As the increase inΔυQ ismore signiﬁcant for the sn-2 chain,we conclude
that both ligand molecules produce ordering effect on the sn-2 chain at
this site. Δ8-THC was also found to possess a capability to increase the
order parameter on the sn-2 chain and the effect ismore profoundwhen
compared with CP55940 and WIN22512-2, as demonstrated by the
larger corresponding increase inΔυQ values (Table 1). In the case of sn-1
chain, CP55940 shows a negligible effect on its order parameter at theDPPC lipid membrane at 30 °C. The ligand-free DPPC membrane bilayer in the gel phase
d the center of the lipid bilayer (A). With 10 mol% WIN55212-2, a broadened 2H-NMR
line-type lineshape from the bilayer center are shown. Cannabinoid ligand-induced
ts to fall in a fast exchange regime (orange color) on the 2H NMR timescale resulting in
in the lipid membrane, these lipid defects could be either clustered (B) or dispersed (C),
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ordering effect on 2′-methylene of the sn-1 chain similar to that
observed previously with Δ8-THC(Table 1).
The 2H-quadrupolar splitting data demonstrate that in the liquid
crystalline phase both CP55940 and WIN55212-2 increase the order
parameter at the lipid interface and suggest that both ligands are
localized toward the membrane surface near the interface (Fig. 4). In
an earlier publication involving the conformational analysis of
CP55940, all three hydroxyl groups of CP55940 were found to orient
toward the upper face of the molecule that allows for a preferred
orientation within the membrane [5,9,15,18,19]. This orientation
favors a close interaction between both the cyclohexane and phenolic
rings of CP55940with the phospholipidmembrane interface (Fig. 4B).
This orientation resembles that observed for Δ8-THC that localizes the
tricyclic terpene structure near the bilayer surface with the long axis
of its tricyclic structure perpendicular to the phospholipid chains. The
tricyclic structure of Δ8-THC results in greater increase of order
parameter in the liquid crystal phase than the bicyclic structures of
CP55940 and WIN55212-2, both of which have greater conforma-
tional ﬂexibility.
We hypothesize that the interaction with the more ﬂexible
aminoalkylindole WIN55212-2 occurs through association of the
morpholino group with polar components of the phospholipid head
groups (Fig. 4C). This would allow the bulky hydrophobic rings to
extend into the membrane interior where they may be accommo-
dated within the hydrophobic acyl chains [22]. Both CP55940 and
WIN55212-2 are located near the bilayer interfacewhere they assume
distinct orientations and exercise acyl chain ordering effects at the
level of themethylene groups near the interface. The differential effect
of CP55940 and WIN55212-2 on the phospholipid membrane, as
reﬂected by the characteristics of the corresponding 2H NMR spectra,
may be attributed to their differences in the speciﬁc ligand location,
conformation and orientation within the lipid bilayer.
The ΔυQ values from 1,2-[16′,16′,16′-2H3] DPPC lipid membrane
terminal methyl groups of both of the acyl chains decreases by 0.3 kHz
and 0.5 kHz with the presence of CP55940 and WIN55212-2,
respectively. This spectral narrowing is an indication of a decrease
of order parameter at the bilayer center resulting from the effects of
ligand modulation and shows that WIN55212-2 exerts a greater
measurable disordering effect. The change of order parameter
induced by CP55940 and WIN55212-2 at the bilayer center are
more modest compared to the effects induced by Δ8-THC [5], which
decreases the ΔυQ by 0.9 kHz. This is consistent with our model
according to which all three amphipathic ligands are anchored at
the bilayer interface and away from the bilayer center (Fig. 4). At that
location, the ligands induce a reduction of the order parameter
at the deeper levels of the bilayer. Because of its more rigid structure,
Δ8-THC is anchored more effectively and hence its higher ability to
perturb the bilayer [4,9]. CP55940 andWIN55212-2 are anchored less
effectively. Additionally, their greater degree of conformational
freedom allows them to be better accommodated among the acyl
chains resulting in less perturbation to the lipid membrane. Hence the
decreases observed in the quadrupolar splitting are more modest
compared to those of Δ8-THC. By contrast, if the ligands were
partitioned at the center of the bilayer, we would expect a local
increase of acyl chain order parameter and an increase in the
quadrupolar splittings, as was observed at the bilayer surface.
In conclusion, our results show that while these cannabinoid
ligands share similar attributes with respect to their effects on DPPC
multilammelar membranes bilayer, there are interesting differences.
The ligands lower the phospholipid membrane phase transition
temperature, increase the lipid sn-2 chain order parameter at the
membrane interface and decrease the order at the center of the
bilayer. The ligands may induce lipid membrane lateral phase
separation at physiological temperatures. During the lipid membrane
phase transition, the collective mobility that allows the interface andthe center of the bilayer to reach the fast exchange regime
simultaneously (2H NMR timescale) is affected. While CP55940 is
more effective at inducing a fast exchange regime at the membrane
interface, WIN55212-2 exerts a greater effect at the center of the
bilayer. In addition, in the liquid crystalline condition, WIN55212-2
increases the order parameter of both sn-1 and sn-2 phospholipid acyl
chains whereas CP55940 only increases the order parameter of 2′-
methylene segment of the sn-2 acyl chain. The changes of the 2′-
methylene order parameter of sn-1 and sn-2, as reﬂected by the
change of corresponding ΔνQ values, is mostly triggered by the
orientation change of the DPPC glycerol backbone [39]. Our results
suggest that the two compounds may have different interaction
modes with the lipid interface. Each ligand may induce a speciﬁc
orientation of the DPPC glycerol backbone, which bestows the
characteristic set of 2′-methylene ΔνQ values on the lipid acyl chains.
These observations suggest that the cannabinoid ligand effects may
involve domain formations within the bilayer and contributions to
their cannabinergic activities are possible through a lipid micro-
domain related mechanism.
The biological effects of cannabinoids are exerted through
membrane proteins that include family A G-protein coupled recep-
tors, speciﬁcally, cannabinoid receptor 1 and 2[26]. A comprehensive
molecular mechanism of how these protein targets interact with their
respective ligands to exert their complex biological functions has yet
to be fully explained. The unique membrane effects of the two
cannabinoid agonists observed in this study may contribute to the
understanding of the activation and functions of these membrane
proteins.
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